Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study
暂无分享,去创建一个
B. Coiffier | R. Bouabdallah | M. Dyer | W. Kim | Á. Illés | V. Ribrag | F. Morschhauser | F. Offner | S. Lim | B. Lemieux | I. Kloos | T. Graef | Ying Luan | R. Vezan | Zakia Felloussi